Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.

Kaur, Sukhbir; Schwartz, Anthony L; Jordan, David G; Soto-Pantoja, David R; Kuo, Bethany; Elkahloun, Abdel G; Mathews Griner, Lesley; Thomas, Craig J; Ferrer, Marc; Thomas, Anish; Tang, Sai-Wen; Rajapakse, Vinodh N; Pommier, Yves; Roberts, David D

Kaur, Sukhbir; Schwartz, Anthony L; Jordan, David G; Soto-Pantoja, David R; Kuo, Bethany; Elkahloun, Abdel G; Mathews Griner, Lesley; Thomas, Craig J; Ferrer, Marc; Thomas, Anish; Tang, Sai-Wen; Rajapakse, Vinodh N; Pommier, Yves; Roberts, David D.

Afiliação

Kaur S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Schwartz AL; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Jordan DG; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Soto-Pantoja DR; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Kuo B; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Elkahloun AG; Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Mathews Griner L; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
Thomas CJ; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
Ferrer M; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
Thomas A; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Tang SW; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Rajapakse VN; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Roberts DD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Front Oncol ; 9: 994, 2019.

Article em En | MEDLINE | ID: mdl-31632920

Palavras-chave

CD47; DNA damage response; epigenetics; prostate cancer; radioresistance; schlafen-11; thrombospondin-1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Radiacao_solar Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google